Eitan AmirProfile page
Professor
Temerty Faculty of Medicine, Department of Medicine
Orcid identifier0000-0002-3706-525X
- ProfessorTemerty Faculty of Medicine, Department of Medicine
- 416 946 4501 Ext.5181 (Work)
- 416 946 6546 (Fax)
- Princess Margaret Cancer Centre, Division of Medical Oncology and Hematology, 610 University Ave, Toronto, ON, M5G 2M9, Canada
GRANTS
- Showing page 1 out of 1
- 1
Showing page 1, grants 1 to 23 of 23
- SPONSORED RESEARCH AGREEMENTThe JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled TrialCanadian Institutes of Health Research1 Sep 2025 - 31 Aug 2029
- SPONSORED RESEARCH AGREEMENTThe JUdicious Surveillance for Trastuzumab Induced Cardiotox icity in the First Year (JUSTIFY) Randomized Controlled Tria lCIHR - Grants (CIHR)1 Mar 2025 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTThe JUdicious Surveillance for Trastuzumab Induced Cardiotox icity in the First Year (JUSTIFY) Randomized Controlled Tria lCIHR - Grants (CIHR)1 Oct 2024 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTAt-home Breast Oncology care Delivered with E-Health solutions – The ABODE Study for Patients Undergoing Neoadjuvant ChemotherapyAHSC AFP Innovation Fund1 Apr 2024 - 31 Mar 2026
- SPONSORED RESEARCH AGREEMENTRandomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in pa tients with advanced cancerCIHR - Grants (CIHR)1 Apr 2024 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTA Multi-Centre Non-Inferiority Randomized Controlled Trial o f STOPping Cardiac MEDications in Patients with Normalized C ancer Therapy Related Cardiac Dysfunction - The STOP-MED CTR CD TrialCIHR - Awards (CIHR)1 Sep 2023 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTA Multi-Centre Non-Inferiority Randomized Controlled Trial o f STOPping Cardiac MEDications in Patients with Normalized C ancer Therapy Related Cardiac Dysfunction – The STOP-MED CTR CD TrialUHN MSH ACADEMIC MEDICAL ORG1 Apr 2023 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTA phase II trial assessing the additional palliative benefit of physiological high-does vitamin D for breast cancer pati ents with bone metastases using pain scores and biochemical markers of bone turnover.Vitamin D Society1 Apr 2023 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTDantrolene as an adjunct to chemotherapy with doxorubicin to reduce or eliminate associated cardiotoxicity to extend or eliminate lifetime maximum dosingPrincess Margaret Cancer Center Innovation Accelerator Fund (IAF)1 Apr 2023 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTNovel Dantrolene Indication: Dantrolene to reduce the cardio toxicity of DoxorubicinPrincess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2023 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTTD Fund for emergency medicine and indigenous health partner shipUHN Foundations1 Apr 2023 - 31 Mar 2025
- SPONSORED RESEARCH AGREEMENTPrecision cardiovascular disease profiling and risk prediction in cancer survivors (PROGRESS): A prospective cohort study.Heart and Stroke Foundation of Canada1 Jul 2022 - 30 Jun 2024
- SPONSORED RESEARCH AGREEMENTThe Impact of COVID-19 on the Diagnosis and Treatment of Breast Cancer (TICTOC): a population-based study. Canadian Institutes of Health ResearchCanadian Institutes of Health Research1 Apr 2022 - 31 Mar 2024
- SPONSORED RESEARCH AGREEMENTA phase II trial assessing the additional palliative benefit of physiological high-does vitamin D for breast cancer pati ents with bone metastases using pain scores and biochemical markers of bone turnover.Vitamin D Society1 Apr 2017 - 31 Dec 2022
- SPONSORED RESEARCH AGREEMENTBreast Medical Oncology Fellowship Fund - Purpose: To Suppor t The Activities Of Medical Oncology Breast Cancer Fellows A t Princess Margaret Cancer Centre/Oci. Funding Various Donor s. Fund Set-Up Requested By: Shannon StuartPrincess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2016 - 31 Mar 2017
- SPONSORED RESEARCH AGREEMENTHold 'Em For Life Breast Cancer Research Fund - Purpose: To Support The Genomic Sequencing Project Related To Breast Can cer At Princess Margaret Cancer Centre/Oci.Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2016 - 31 Mar 2017
- SPONSORED RESEARCH AGREEMENTNeoadjuvant Breast Cancer Treatment Program Fund - Purpose: To Facilitate The Creation And Operationalizing Of The Neoad juvant Breast Cancer Treatment ProgramPrincess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2016 - 31 Mar 2017
- SPONSORED RESEARCH AGREEMENTHold 'Em For Life Breast Cancer Research Fund. Researchto Su pport The Genomic Sequencing Project Related To Breast Cance r At Princess Margaret Cancer Centre/Oci.Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2015 - 31 Mar 2016
- SPONSORED RESEARCH AGREEMENTImpact That Pcodr Has On Cancer Drug Funding In CanadaInactive - St Michael's Hospital He (St. Michael's Hospital)1 Apr 2015 - 31 Mar 2016
- SPONSORED RESEARCH AGREEMENTPMHF: A Randomised Pilot study comparing the efficacy of 4-w eekly versus 12-weekly intravenous Bisphosphonnate therapy i n women with low risk bone metastases from breast cancer usi ng bone resorption markers.University Health Network1 Apr 2013 - 31 Mar 2014
- SPONSORED RESEARCH AGREEMENTpurpose: to provide funding for research for residents and f ellows funds: donations from individuals and honourariums (s ic) notes: fund start up requested by eitan amirPrincess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2013 - 31 Mar 2014
- SPONSORED RESEARCH AGREEMENTpurpose: to support the genomic sequencing project related t o breast cancerat pmh/oci.Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2013 - 31 Mar 2014
- SPONSORED RESEARCH AGREEMENTFund : Hold 'em for Life Breast Cancer Research Fund ; Resea rch purpose: to support the genomic sequencing project relat ed to breast cancerat pmh/oci.Princess Margaret Hospital Foundati (The Princess Margaret Cancer Foundation)1 Apr 2012 - 31 Mar 2013